Lilly's $2.75B AI Drug Deal + Apple's Strategy Shift

This episode covers Lilly's $2.75 billion deal for AI-discovered drugs, Apple's platform-based AI strategy, and New Zealand startup Halter raising $220 million for AI cow collars. It also touches on Bluesky's Attie launch and Stanford's findings on AI chatbots validating bad…

Listen